New Studies Support Benefits of CRS/HIPEC Treatment in Peritoneal Mesothelioma, According to Surviving Mesothelioma

Share Article

Two new studies in Canada and France indicate that peritoneal mesothelioma patients who undergo cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are more likely to live longer and enjoy a good quality of life.

Mesothelioma Surgery Studies

Good News on CRS/HIPEC for Mesothelioma

This study demonstrated that CRS and HIPEC provide long-term survival irrespective of PC [peritoneal cancer] origin...

Scientists in Lyon, France and British Columbia have released studies on the survival and quality of life benefits from the surgical procedure known as CRS with HIPEC. Surviving Mesothelioma has just posted the details on the website. Click here to read the full article.

The University of Lyon study focused on peritoneal cancer patients, including 84 with mesothelioma, treated with CRS/HIPEC since 1989.

“This study demonstrated that CRS and HIPEC provide long-term survival irrespective of PC [peritoneal cancer] origin, and survival improves with experience,” writes author and researcher Guillaume Passot, MD, in the Journal of Surgical Oncology.

A second study conducted by University of British Columbia researchers and published in the Annals of Surgical Oncology finds that even patients who have major complications after CRS/HIPEC tend to have a quality of life equal to the no-complication group in about 6 months.

“One of the most hopeful messages of these studies is that, the longer doctors perform CRS/HIPEC, the better the the outcomes for their patients seem to get. This should be reassuring for mesothelioma patients considering the procedure,” says Alex Strauss, Surviving Mesothelioma’s Managing Editor.

For complete details of both new studies, see Specialized Mesothelioma Procedure Provides Long Survival, Good Life Quality, now available on the Surviving Mesothelioma website.

Passot, G, et al, “What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures”, April25, 2016, Journal of Surgical Oncology, Epud ahead of print,

Hamilton, TD, et al, “Impact of Major Complications on Patients' Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy”, April 19, 2016, Annals of Surgical Oncology, Epub ahead of print,

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website